| __timestamp | HUTCHMED (China) Limited | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72049000 | 570979 |
| Thursday, January 1, 2015 | 110777000 | 2185000 |
| Friday, January 1, 2016 | 156328000 | 4554000 |
| Sunday, January 1, 2017 | 175820000 | 3605000 |
| Monday, January 1, 2018 | 143944000 | 5527000 |
| Tuesday, January 1, 2019 | 160152000 | 5234000 |
| Wednesday, January 1, 2020 | 188519000 | 6126000 |
| Friday, January 1, 2021 | 258234000 | 6784000 |
| Saturday, January 1, 2022 | 311103000 | 7592000 |
| Sunday, January 1, 2023 | 384447000 | 11450000 |
Infusing magic into the data realm
In the ever-evolving landscape of the pharmaceutical industry, understanding cost efficiency is crucial. HUTCHMED (China) Limited and Travere Therapeutics, Inc. offer a fascinating study in contrasts. Over the past decade, HUTCHMED has seen its cost of revenue grow by over 400%, peaking in 2023. This reflects its aggressive expansion and investment in research and development. In contrast, Travere Therapeutics has maintained a more modest growth, with its cost of revenue increasing by approximately 100% over the same period. This suggests a more conservative approach, focusing on optimizing existing operations.
Cost of Revenue: Key Insights for Johnson & Johnson and HUTCHMED (China) Limited
Cost of Revenue Trends: AstraZeneca PLC vs HUTCHMED (China) Limited
Cost of Revenue Comparison: Zoetis Inc. vs Travere Therapeutics, Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited's Expenses
BeiGene, Ltd. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Viatris Inc. vs HUTCHMED (China) Limited
Lantheus Holdings, Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cytokinetics, Incorporated vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: CRISPR Therapeutics AG vs Travere Therapeutics, Inc.
Cost of Revenue: Key Insights for Perrigo Company plc and HUTCHMED (China) Limited
Cost of Revenue Comparison: HUTCHMED (China) Limited vs Xencor, Inc.